Serious but rare adverse effects associated with injectable GLP-1 receptor agonists include acute pancreatitis, gallbladder disease (cholecystitis and cholelithiasis), and potential thyroid effects
We didnt know that GLP-1 would reduce appetite and be useful for weight loss, Drucker said
Do not increase both compounds simultaneously
Cells 9 , 70 (2019)
A person with a BMI of 28 and a history of gestational diabetes may benefit from one of these medications to lose weight while concomitantly mastering lifestyle behaviors, and then transition off the weight management medications to lifestyle alone, says Linda Gigliotti, MS, RDN, CDCES, CSOWM, an obesity and weight management specialist based in Irvine, California
Tirzepatide reports nausea in 2533% and vomiting in 16% depending on dose and population studied